Geriatrics and Gerontology

A topic in the Science corpus, drawn from 739 papers.

Trusted voices in Geriatrics and Gerontology

Ordered by the trust Geriatrics and Gerontology's own network concentrates on each researcher, most first.

  1. L. Guarente — trusted by 159 researchers here
  2. Kenneth Rockwood — trusted by 36 researchers here
  3. Arnold Mitnitski — trusted by 36 researchers here
  4. M. Haigis — trusted by 28 researchers here
  5. S. Imai — trusted by 22 researchers here
  6. D. Sinclair — trusted by 25 researchers here
  7. M. Levine — trusted by 21 researchers here
  8. Roy A. Frye — trusted by 16 researchers here
  9. A. Mitchell — trusted by 20 researchers here
  10. E. Verdin — trusted by 21 researchers here
  11. Su-Ju Lin — trusted by 13 researchers here
  12. M. Eccles — trusted by 11 researchers here

Most-cited papers in Geriatrics and Gerontology

Ordered by the recorded citation count from the source corpus; a citation is not an endorsement.

  1. Frailty in older adults: evidence for a phenotype. (2001, The journals of gerontology. Series A, Biological sciences and medical sciences) — 22,343 citations
  2. The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease (2011, Alzheimer's & Dementia) — 16,320 citations
  3. Sarcopenia: revised European consensus on definition and diagnosis (2018, Age and Ageing) — 11,542 citations
  4. Sarcopenia: European consensus on definition and diagnosis (2010, Age and Ageing) — 8,262 citations
  5. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission (2020, The Lancet) — 7,984 citations
  6. A global clinical measure of fitness and frailty in elderly people (2005, Canadian Medical Association Journal) — 7,935 citations
  7. Dose translation from animal to human studies revisited (2007, The FASEB Journal) — 5,969 citations
  8. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 (2020, The Lancet) — 5,916 citations
  9. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. (2000, New England Journal of Medicine) — 5,799 citations
  10. Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment. (2020, Journal of the American Medical Directors Association) — 5,702 citations
  11. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. (2005, New England Journal of Medicine) — 5,425 citations
  12. Adherence to medication. (2005, New England Journal of Medicine) — 4,571 citations
  13. SF-36 Health Survey Update (2000, Spine) — 4,490 citations
  14. Gait Speed and Survival in Older Adults (2011, Journal of the American Medical Association (JAMA)) — 4,226 citations
  15. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. (2006, Cell) — 4,168 citations
  16. Adherence to medication. (2005, New England Journal of Medicine) — 4,163 citations
  17. Frailty in elderly people. (2007, The Lancet) — 4,006 citations
  18. Therapeutic potential of resveratrol: the in vivo evidence (2006, Nature reviews. Drug discovery) — 3,906 citations
  19. Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. (2004, The journals of gerontology. Series A, Biological sciences and medical sciences) — 3,896 citations
  20. CONSORT 2010 statement: extension to randomised pilot and feasibility trials (2016, Pilot and Feasibility Studies) — 3,819 citations
  21. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan (2003, Nature) — 3,808 citations
  22. Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. (2014, Journal of the American Medical Directors Association) — 3,713 citations
  23. Frailty Consensus: A Call to Action (2013, Journal of the American Medical Directors Association) — 3,628 citations
  24. Self-eating and self-killing: crosstalk between autophagy and apoptosis (2007, Nature reviews. Molecular cell biology) — 3,587 citations
  25. Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase (2000, Nature) — 3,482 citations
  26. Stress-Dependent Regulation of FOXO Transcription Factors by the SIRT1 Deacetylase (2004, Science) — 3,348 citations
  27. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients (2004, British medical journal) — 3,313 citations
  28. Predictive Validity of a Medication Adherence Measure in an Outpatient Setting (2008, The Journal of Clinical Hypertension) — 3,206 citations
  29. A standard procedure for creating a frailty index (2008, BMC Geriatrics) — 3,204 citations
  30. AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity (2009, Nature) — 3,126 citations
  31. Low Relative Skeletal Muscle Mass (Sarcopenia) in Older Persons Is Associated with Functional Impairment and Physical Disability (2002, Journal of The American Geriatrics Society) — 3,111 citations
  32. Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty (2018, Nature Reviews Cardiology) — 3,019 citations
  33. Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. (2011, Journal of the American Medical Directors Association) — 3,007 citations
  34. The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study. (2006, The journals of gerontology. Series A, Biological sciences and medical sciences) — 2,905 citations
  35. Lower extremity function and subsequent disability: consistency across studies, predictive models, and value of gait speed alone compared with the short physical performance battery. (2000, The journals of gerontology. Series A, Biological sciences and medical sciences) — 2,816 citations
  36. Prevalence of Frailty in Community‐Dwelling Older Persons: A Systematic Review (2012, Journal of The American Geriatrics Society) — 2,805 citations
  37. Modulation of NF‐κB‐dependent transcription and cell survival by the SIRT1 deacetylase (2004, EMBO Journal) — 2,787 citations
  38. Frailty in relation to the accumulation of deficits. (2007, The journals of gerontology. Series A, Biological sciences and medical sciences) — 2,778 citations
  39. ESPEN guidelines for nutrition screening 2002. (2003, Clinical Nutrition) — 2,734 citations
  40. A review of the measurement of grip strength in clinical and epidemiological studies: towards a standardised approach. (2011, Age and Ageing) — 2,716 citations
  41. 2016 Alzheimer's disease facts and figures (2016, Alzheimer's & Dementia) — 2,690 citations
  42. What is polypharmacy? A systematic review of definitions (2017, BMC Geriatrics) — 2,688 citations
  43. hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. (2001, Cell) — 2,660 citations
  44. ESPEN guidelines on nutrition in cancer patients. (2017, Clinical Nutrition) — 2,628 citations
  45. Accumulation of Deficits as a Proxy Measure of Aging (2001, TheScientificWorldJournal) — 2,627 citations
  46. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. (2003, Archives of Internal Medicine) — 2,599 citations
  47. COSMIN guideline for systematic reviews of patient-reported outcome measures (2018, Quality of Life Research) — 2,569 citations
  48. The ubiquitin kinase PINK1 recruits autophagy receptors to induce mitophagy (2015, Nature) — 2,558 citations
  49. Rehospitalizations among patients in the Medicare fee-for-service program. (2009, New England Journal of Medicine) — 2,553 citations
  50. A systematic review of the associations between dose regimens and medication compliance. (2001, Clinical Therapeutics) — 2,482 citations

Most active researchers

By papers in this topic: a volume measure, not trust.